ANI Pharmaceuticals | ANIP - EPS Earnings Per Share



ANI Pharmaceuticals reported $1.8 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q2 Jun/2025 1.80 1.43 1.02 Aug/08 2025
FY2025Q1 Mar/2025 1.70 1.12 1.21 May/09 2025
FY2024Q4 Dec/2024 1.63 1.45 1.00 Feb/28 2025
FY2024Q3 Sep/2024 1.34 1.08 1.27 Nov/08 2024
FY2024Q2 Jun/2024 1.02 0.95 1.28 Aug/06 2024
FY2024Q1 Mar/2024 1.21 0.98 1.17 May/10 2024
FY2023Q4 Dec/2023 1.00 0.85 0.76 Feb/29 2024
FY2023Q3 Sep/2023 1.27 0.84 0.64 Nov/08 2023
FY2023Q2 Jun/2023 1.28 0.67 0.13 Aug/09 2023
FY2023Q1 Mar/2023 1.17 0.36 -0.12 May/08 2023
FY2022Q4 Dec/2022 0.76 0.66 0.54 Mar/09 2023
FY2022Q3 Sep/2022 0.64 0.55 1.01 Nov/09 2022


Eps Change Date
AbbVie USD 2.97 0.51 Jun/2025
ANI Pharmaceuticals USD 1.8 0.1 Jun/2025
Aurora Cannabis CAD -0.26 0.84 Jun/2025
Canopy Growth CAD -0.22 0.89 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
Hikma Pharmaceutical USD 0.6 0.41 Dec/2024
Knight Therapeutics CAD 0 0.02 Sep/2024
Novartis USD 2.06 0.08 Jun/2025
Perrigo USD 0.57 0.03 Jun/2025
Sun Pharmaceuticals INR 11.2 0.4 Jun/2025
Teva Pharmaceutical Industries USD 2.22 0.34 Jun/2025